1. Z Shank, Lincof AM, Young JB: Anthracycline induced cardiotoxicity. Ann Int Med 125: 930–942, 1996
2. Smylie M: Liposomal doxorubicin in the treatment of metastatic breast cancer. In: Nabholtz JM, Tonkin K, Aapro MS et al. (eds) Breast Cancer Management. Martin Duntiz, London, 2000, p 99
3. Ellis MJ, Hayes DF, Lippman ME: Treatment of metastatic breast cancer. In: Harris JR, Lippman ME, Morrow M et al. (eds) Diseases of the Breast. Lippincott Williams & Wilkins, Philadelphia, 2000, p 749
4. Hern RP, Smith IE, Ebbs SR: Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimen. Br J Cancer 67: 801–805, 1993
5. Fossati R, Confalonieri C, Torri V et al.: Cytotoxic and hormonal treatment for metastatic breast cancer. A systematic review of published randomized trials involving 31510 women. J Clin Oncol 10: 3439–3460, 1998